Targeting copper metabolism: a promising strategy for cancer treatment
- PMID: 37564178
- PMCID: PMC10411510
- DOI: 10.3389/fphar.2023.1203447
Targeting copper metabolism: a promising strategy for cancer treatment
Abstract
Copper is an essential micronutrient that plays a critical role in many physiological processes. However, excessive copper accumulation in cancer cells has been linked to tumor growth and metastasis. This review article explores the potential of targeting copper metabolism as a promising strategy for cancer treatment. Excessive copper accumulation in cancer cells has been associated with tumor growth and metastasis. By disrupting copper homeostasis in cancer cells and inducing cell death through copper-dependent mechanisms (cuproplasia and cuprotosis, respectively), therapies can be developed with improved efficacy and reduced side effects. The article discusses the role of copper in biological processes, such as angiogenesis, immune response, and redox homeostasis. Various approaches for targeting copper metabolism in cancer treatment are examined, including the use of copper-dependent enzymes, copper-based compounds, and cuprotosis-related genes or proteins. The review also explores strategies like copper chelation therapy and nanotechnology for targeted delivery of copper-targeting agents. By understanding the intricate network of cuprotosis and its interactions with the tumor microenvironment and immune system, new targets for therapy can be identified, leading to improved cancer treatment outcomes. Overall, this comprehensive review highlights the significant potential of targeting copper metabolism as a promising and effective approach in cancer treatment, while providing valuable insights into the current state of research in this field.
Keywords: cancer treatment; copper; cuprotosis; metabolism; tumor microenvironment.
Copyright © 2023 Kong and Sun.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
The potential value of cuprotosis (copper-induced cell death) in the therapy of clear cell renal cell carcinoma.Am J Cancer Res. 2022 Aug 15;12(8):3947-3966. doi: 10.62347/ETJH6697. eCollection 2022. Am J Cancer Res. 2022. PMID: 36119838 Free PMC article.
-
Targeting cuproplasia and cuproptosis in cancer.Nat Rev Clin Oncol. 2024 May;21(5):370-388. doi: 10.1038/s41571-024-00876-0. Epub 2024 Mar 14. Nat Rev Clin Oncol. 2024. PMID: 38486054 Review.
-
A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma.Cell Biosci. 2022 Dec 29;12(1):209. doi: 10.1186/s13578-022-00948-7. Cell Biosci. 2022. PMID: 36581992 Free PMC article.
-
Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies.Cancer Lett. 2023 May 1;561:216157. doi: 10.1016/j.canlet.2023.216157. Epub 2023 Apr 1. Cancer Lett. 2023. PMID: 37011869 Review.
-
Cuproptosis: Harnessing Transition Metal for Cancer Therapy.ACS Nano. 2023 Oct 24;17(20):19581-19599. doi: 10.1021/acsnano.3c07775. Epub 2023 Oct 11. ACS Nano. 2023. PMID: 37820312 Review.
Cited by
-
Copper Promotes LPS-Induced Inflammation via the NF-кB Pathway in Bovine Macrophages.Biol Trace Elem Res. 2024 Dec;202(12):5479-5488. doi: 10.1007/s12011-024-04107-6. Epub 2024 Feb 20. Biol Trace Elem Res. 2024. PMID: 38376728
-
Copper in Gynecological Diseases.Int J Mol Sci. 2023 Dec 17;24(24):17578. doi: 10.3390/ijms242417578. Int J Mol Sci. 2023. PMID: 38139406 Free PMC article. Review.
-
Comprehensive landscape of cell death mechanisms: from molecular cross-talk to therapeutic innovation in oncology.Front Cell Dev Biol. 2025 Jul 16;13:1611055. doi: 10.3389/fcell.2025.1611055. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40741332 Free PMC article. Review.
-
Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma.Heliyon. 2025 Jan 4;11(1):e41600. doi: 10.1016/j.heliyon.2024.e41600. eCollection 2025 Jan 15. Heliyon. 2025. PMID: 39866451 Free PMC article.
-
An up-To-Date Review of Elesclomol and Its Nano-Formulations in Cancer Therapy.Cancer Rep (Hoboken). 2025 Apr;8(4):e70193. doi: 10.1002/cnr2.70193. Cancer Rep (Hoboken). 2025. PMID: 40195280 Free PMC article. Review.
References
-
- Agarwal A., Kasinathan A., Ganesan R., Balasubramanian A., Bhaskaran J., Suresh S., et al. (2018). Curcumin induces apoptosis and cell cycle arrest via the activation of reactive oxygen species–independent mitochondrial apoptotic pathway in Smad4 and p53 mutated colon adenocarcinoma HT29 cells. Nutr. Res. 51, 67–81. 10.1016/j.nutres.2017.12.011 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources